Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Disc Dynamics was a medical technology company specializing in the development of minimally invasive spinal treatments. The company's primary innovation was the DASCOR Disc Arthroplasty System, a nucleus replacement technology that used an injectable, in situ curable polymer to restore spinal disc function. By mimicking the natural biomechanics of the nucleus pulposus, the system aimed to treat degenerative disc disease while preserving the surrounding spinal structure. The technology was designed to be delivered through a small incision, potentially reducing recovery times compared to traditional fusion surgery. The company was acquired by Stryker in 2002 to expand its presence in the spinal arthroplasty market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Disc Dynamics.